Lumature Wealth Partners’s Pfizer PFE Stock Holding History

Lumature Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$29.1K	Hold	792	–	–	0.02%	252
2023 Q1	$32.3K	Hold	792	–	–	0.02%	243
2022 Q4	$40.6K	Sell	792 -5,656	-88%	-$271K	0.02%	230
2022 Q3	$282K	Hold	6,448	–	–	0.15%	108
2022 Q2	$338K	Buy	6,448 +292	+5%	+$14.9K	0.15%	104
2022 Q1	$319K	Hold	6,156	–	–	0.13%	115
2021 Q4	$364K	Hold	6,156	–	–	0.14%	117
2021 Q3	$265K	Hold	6,156	–	–	0.11%	123
2021 Q2	$241K	Buy	6,156 +72	+1%	+$2.8K	0.1%	124
2021 Q1	$220K	Sell	6,084 -111	-2%	-$3.94K	0.12%	115
2020 Q4	$228K	Buy	+6,195	New	+$227K	0.22%	112

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lumature Wealth Partners's PFE Position: Q2 2023 in Review

Lumature Wealth Partners held its Pfizer (PFE) position steady in Q2 2023 at 792 shares worth $29.1K. The position accounts for 0.02% of the portfolio, ranked #252.

Lumature Wealth Partners first reported a position in PFE in Q4 2020 and has held it in 11 quarters since. The position peaked at $364K in Q4 2021. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Lumature Wealth Partners held 792 shares of Pfizer worth $29.1K as of Q2 2023.
Lumature Wealth Partners left its Pfizer share count unchanged in Q2 2023.
Pfizer made up 0.02% of Lumature Wealth Partners's portfolio in Q2 2023, its #252 holding.
Lumature Wealth Partners first reported a position in Pfizer in Q4 2020 and has held it in 11 quarters since.
Lumature Wealth Partners's Pfizer position peaked at $364K in Q4 2021.
3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.